Hugues Richard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hugues Richard has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Marie-Claude Rousseau
Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique (INRS), Laval, Canada
32 shared publications - Marie-Elise Parent
Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada
32 shared publications - Charlotte Salmon
Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France
28 shared publications - Miceline Mesidor
Institut national de la recherche scientifique, Centre Armand-Frappier Santé Biotechnologie, Laval, Canada; Université de Montréal, Faculté de Pharmacie, Montréal, Canada
28 shared publications - Andrea R. Spence
Center for Clinical Epidemiology and Community Studies Jewish General Hospital Montreal Quebec Canada
27 shared publications - Deborah Weiss
Department of National Defense, Government of Canada, Ottawa, Ontario, Canada
27 shared publications
Latest Publications
- Open Access
- 30 July 2024
- Published by Elsevier in Cancer Epidemiology
- Vol. 92, 102635
2D:4D digit ratio as a potential marker for prostate cancer risk
- 30 July 2024
- Published by Elsevier in Cancer Epidemiology
- Vol. 92, 102635
Open Access2D:4D digit ratio as a potential marker for prostate cancer risk
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Cohort Profile Update: The Québec Birth Cohort on Immunity and Health (CO·MMUNITY)
The overarching aim of the Quebec Birth Cohort on Immunity and Health, established in 2010, was to assess the occurrence of autoimmune and inflammatory diseases in relation to a non-specific stimulation of the immune function in early age, resulting from Bacillus Calmette-Guerin (BCG) vaccination. 1 It was originally set up to estimate the association of BCG vaccination with childhood diabetes and asthma. All individuals born in the province of Quebec, Canada, in 1974 after at least 32 weeks of gestation were eligible. Probabilistic linkage allowed the merging of data from the Birth Registry and the Healthcare Registration File, constituting the cohort base. 1 Data were obtained from the Quebec BCG vaccination registry and administrative health databases. In total, 81 496 individuals were successfully linked and included in the cohort (90.5% of those who were eligible). Data were extracted until 1994 and included sociodemographic characteristics, vital status and use of health services for asthma, allergic diseases and diabetes. Validated algorithms were applied to identify disease incidence based on administrative health data. Additional data on potential confounders of the association between BCG vaccination and asthma were collected using a two-stage sampling approach with a balanced design (Survey on Childhood Environment and Allergic Diseases, 2012). 2 Equal numbers of participants were randomly sampled among four groups defined by BCG vaccination (yes/no) and asthma status (yes/no). Information collected from the 1643 participants included sociodemographic, perinatal, environmental and health- and immunization-related factors unavailable in administrative databases. 1–3
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Cohort Profile Update: The Québec Birth Cohort on Immunity and Health (CO·MMUNITY)
The overarching aim of the Quebec Birth Cohort on Immunity and Health, established in 2010, was to assess the occurrence of autoimmune and inflammatory diseases in relation to a non-specific stimulation of the immune function in early age, resulting from Bacillus Calmette-Guerin (BCG) vaccination. 1 It was originally set up to estimate the association of BCG vaccination with childhood diabetes and asthma. All individuals born in the province of Quebec, Canada, in 1974 after at least 32 weeks of gestation were eligible. Probabilistic linkage allowed the merging of data from the Birth Registry and the Healthcare Registration File, constituting the cohort base. 1 Data were obtained from the Quebec BCG vaccination registry and administrative health databases. In total, 81 496 individuals were successfully linked and included in the cohort (90.5% of those who were eligible). Data were extracted until 1994 and included sociodemographic characteristics, vital status and use of health services for asthma, allergic diseases and diabetes. Validated algorithms were applied to identify disease incidence based on administrative health data. Additional data on potential confounders of the association between BCG vaccination and asthma were collected using a two-stage sampling approach with a balanced design (Survey on Childhood Environment and Allergic Diseases, 2012). 2 Equal numbers of participants were randomly sampled among four groups defined by BCG vaccination (yes/no) and asthma status (yes/no). Information collected from the 1643 participants included sociodemographic, perinatal, environmental and health- and immunization-related factors unavailable in administrative databases. 1–3
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 2. Directed acyclic graph of the association between chest hair amount and prostate cancer. In green, variables of interest. In orange, potential confounding factors (due to the paucity of reports on risk factors in the literature, we elected to take a conservative approach and limited adjustments to age and ancestry).
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 2. Directed acyclic graph of the association between chest hair amount and prostate cancer. In green, variables of interest. In orange, potential confounding factors (due to the paucity of reports on risk factors in the literature, we elected to take a conservative approach and limited adjustments to age and ancestry).
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 7. Association between joint exposure of baldness and chest hair amount, and odds of prostate cancer, according to cancer aggressiveness (Gleason score <8, Gleason score ≥ 8), Prostate Cancer & Environment Study, Montreal, Canada, 2005–2012
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 7. Association between joint exposure of baldness and chest hair amount, and odds of prostate cancer, according to cancer aggressiveness (Gleason score <8, Gleason score ≥ 8), Prostate Cancer & Environment Study, Montreal, Canada, 2005–2012
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 2. Selection criteria for the number of trajectories, using controls only
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 2. Selection criteria for the number of trajectories, using controls only
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 4. Association between joint exposure of baldness and chest hair amount, and odds of prostate cancer, overall and by cancer aggressiveness, after restricting to participants who had been screened for prostate cancer in the 2 years preceding the index date, Prostate Cancer & Environment Study, Montreal, Canada, 2005–2012
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 4. Association between joint exposure of baldness and chest hair amount, and odds of prostate cancer, overall and by cancer aggressiveness, after restricting to participants who had been screened for prostate cancer in the 2 years preceding the index date, Prostate Cancer & Environment Study, Montreal, Canada, 2005–2012
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 2. Selection criteria for the number of trajectories, using controls only
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Table 2. Selection criteria for the number of trajectories, using controls only
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 4. Forest plot of studies on vertex baldness and prostate cancer risk. Supplementary figure 4 shows the forest plot depicting the main results obtained in studies investigating the link between vertex baldness, age of onset, severity and prostate cancer.
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 4. Forest plot of studies on vertex baldness and prostate cancer risk. Supplementary figure 4 shows the forest plot depicting the main results obtained in studies investigating the link between vertex baldness, age of onset, severity and prostate cancer.
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Data from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Background:The link between hormones and hair growth is well established. Inconsistent associations have been found between hair patterns and cancer of the prostate, a hormone-dependent organ. We assessed vertex baldness trajectories, chest hair amount, and their relationships with the odds of developing prostate cancer in a large case–control study in Montreal, Canada.Methods:In-person interviews were conducted with 1,931 incident prostate cancer cases and 1,994 population-based age-matched (±5 years) controls. Participants reported their hair patterns using the validated Hamilton–Norwood scale of baldness for 10-year increments starting at age 30, and their current amount of chest hair. Group-based trajectories were used to identify men sharing similar patterns of vertex baldness severity over adulthood. Multivariable logistic regression assessed associations between indicators of baldness (frontal, vertex, age at onset, severity, and trajectories), chest hair, and odds of prostate cancer.Results:Vertex balding onset at age 30 was associated with increased odds of overall prostate cancer [Odds ratio (OR), 1.30; 95% confidence interval (CI), 1.03–1.64]. Men in the trajectory characterized by early moderate vertex baldness and developing severe baldness had increased odds of overall (OR, 1.42; 95% CI, 1.03–1.96) and especially aggressive prostate cancer (OR, 1.98; 95% CI, 1.21–3.22) compared with men without baldness. Men with little chest hair had higher odds of aggressive tumors than those with a moderate amount/a lot of chest hair.Conclusions:Early-onset moderate vertex baldness that progresses and having little chest hair may be useful biomarkers of aggressive prostate cancer.Impact:Integration of early-onset vertex balding patterns into risk prediction models of aggressive prostate cancer should be envisaged.
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Background:The link between hormones and hair growth is well established. Inconsistent associations have been found between hair patterns and cancer of the prostate, a hormone-dependent organ. We assessed vertex baldness trajectories, chest hair amount, and their relationships with the odds of developing prostate cancer in a large case–control study in Montreal, Canada.Methods:In-person interviews were conducted with 1,931 incident prostate cancer cases and 1,994 population-based age-matched (±5 years) controls. Participants reported their hair patterns using the validated Hamilton–Norwood scale of baldness for 10-year increments starting at age 30, and their current amount of chest hair. Group-based trajectories were used to identify men sharing similar patterns of vertex baldness severity over adulthood. Multivariable logistic regression assessed associations between indicators of baldness (frontal, vertex, age at onset, severity, and trajectories), chest hair, and odds of prostate cancer.Results:Vertex balding onset at age 30 was associated with increased odds of overall prostate cancer [Odds ratio (OR), 1.30; 95% confidence interval (CI), 1.03–1.64]. Men in the trajectory characterized by early moderate vertex baldness and developing severe baldness had increased odds of overall (OR, 1.42; 95% CI, 1.03–1.96) and especially aggressive prostate cancer (OR, 1.98; 95% CI, 1.21–3.22) compared with men without baldness. Men with little chest hair had higher odds of aggressive tumors than those with a moderate amount/a lot of chest hair.Conclusions:Early-onset moderate vertex baldness that progresses and having little chest hair may be useful biomarkers of aggressive prostate cancer.Impact:Integration of early-onset vertex balding patterns into risk prediction models of aggressive prostate cancer should be envisaged.
- Open Access
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 2. Directed acyclic graph of the association between chest hair amount and prostate cancer. In green, variables of interest. In orange, potential confounding factors (due to the paucity of reports on risk factors in the literature, we elected to take a conservative approach and limited adjustments to age and ancestry).
- 9 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
Supplementary Figure 2. Directed acyclic graph of the association between chest hair amount and prostate cancer. In green, variables of interest. In orange, potential confounding factors (due to the paucity of reports on risk factors in the literature, we elected to take a conservative approach and limited adjustments to age and ancestry).